Inventor · disambiguated record
Jenna Nguyen
Also filed as: NGUYEN JENNA
0 granted patents·8 pending applications·0 citations·filing 2020–2022
Files withELPIS BIOPHARMACEUTICALS8
Top patents by PatentIndex Score
8 records- 0157US2024368275A1Anti-nectin4 antibodies and multi-specific protein complexes comprising suchELPIS BIOPHARMACEUTICALS·Filed 2022·Application pending·0 cites
- 0257US2025340646A1Anti-pd-l1 monoclonal antibodies and fusion proteins with interleukin-15, interleukin-15 receptor alpha, or interleukin-2ELPIS BIOPHARMACEUTICALS·Filed 2022·Application pending·0 cites
- 0356US2024336683A1Antibodies specific to sialic acid-binding ig-like lectin 15 and uses thereofELPIS BIOPHARMACEUTICALS·Filed 2022·Application pending·0 cites
- 0454US2023220053A1ANTI-SARS-CoV-2 ANTIBODIES AND USES THEREOFELPIS BIOPHARMACEUTICALS·Filed 2021·Application pending·0 cites
- 0551US2024082402A1Bispecific chimeric antigen receptors binding to cd19 and cd22ELPIS BIOPHARMACEUTICALS·Filed 2022·Application pending·0 cites
- 0649US2022298257A1Anti-cd22 antibodies and uses thereofELPIS BIOPHARMACEUTICALS·Filed 2020·Application pending·0 cites
- 0749US2022289843A1Anti-cd19 antibodies and uses thereofELPIS BIOPHARMACEUTICALS·Filed 2020·Application pending·0 cites
- 0846US2023002466A1Engineered interleukin-2 receptor beta agonistsELPIS BIOPHARMACEUTICALS·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jenna Nguyen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →